-
SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
B3C newswire
November 06, 2023
SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in data-driven medicine today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK).
-
NHS invests £20m to fast-track measures for quick cancer diagnosis
pharmatimes
July 15, 2021
The NHS announced 13rd that it was investing £20m to fast-track measures for rapid cancer diagnosis, in a bid to get more people checked for cancer.
-
Low-Dose Aspirin Does Not Cut Death From Prostate Cancer
drugs
March 05, 2019
Low-dose aspirin use does not appear to reduce the overall risk for prostate cancer death, according to a study published online March 5 in the Annals of Internal Medicine.
-
Risk for Suicide Increased in Year After Cancer Diagnosis
drugs
January 08, 2019
Patients with a cancer diagnosis have an increased risk for suicide during the first year after their diagnosis compared with the general population.....
-
NHS pilots ‘one-stop shops’ for cancer diagnosis
pharmatimes
July 18, 2018
NHS England is rolling out a stream of ‘one-stop shops’ across the country in the hope of speeding up diagnosis of cancer.
-
UK trails behind EU in cancer diagnosis & treatment
europeanpharmaceuticalreview
July 19, 2017
A new report shows that the UK is trailing behind the rest of Europe in the diagnosis and treatment of cancer.
-
Exercise Rates Often Decline After Cancer Diagnosis
drugs.com
January 24, 2017
Exercise can help cancer patients cope with their treatment, but as many as 75 percent reduce their physical activity after diagnosis, a new study finds.